JNJ Johnson & Johnson
JNJ Johnson & Johnson
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 2 scans as of 2026-08-17 2 bull converging
POC $172.53 · VWAP $217.21 · +20.8% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 related perspectives
JNJ Price Structure
Loading timeframes…
Peers
Every watchlist JNJ belongs to, members best 30-day change first — JNJ highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@consumer-staples
@healthcare-scan
@healthcare
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Against street estimates
How JNJ's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about JNJ from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 58 days ago · Jun 21
- Johnson & Johnson (JNJ) Earnings Date and Reports 2026
- Johnson & Johnson (JNJ) Financials 2026 - Income Statement
- Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing
- New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase) data demonstrate the strength of a bispecific combo
- JNJ Earnings Q2 2026: What Investors Need to Know
JNJ research tape
72 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.